61 to 70 of 80 Results
Nov 7, 2022 -
Prospective evaluation of the specificity of serological tests for Human African Trypanosomiasis: documentation and data
Adobe PDF - 240.9 KB -
MD5: 7312d18864a1bb6bdd6f8fc4788f448a
Informed consent form and assent form (in French), PDF version |
Nov 7, 2022 -
Prospective evaluation of the specificity of serological tests for Human African Trypanosomiasis: documentation and data
Adobe PDF - 699.5 KB -
MD5: f454f320ca38fece7b7f4c84d8ce069e
Study protocol (in French), PDF version |
Oct 13, 2022 - DiTECT-HAT-WP2
Lejon, Veerle; Camara, Oumou; Camara, Mamadou; Ilboudo, Hamidou; Kaboré, Jacques; Compaoré, Charlie Franck Alfred; Buscher, Philippe; Bucheton, Bruno, 2022, "Passive case detection of Human African Trypanosomiasis in Guinea: symptoms and signs, rapid diagnostic test results and laboratory test results", https://doi.org/10.23708/ZDD0OW, DataSuds, V1, UNF:6:5xfmuyoW9wsYi66d23V96w== [fileUNF]
In the last decade, the prevalence of Trypanosoma brucei gambiense human African trypanosomiasis (HAT) has fallen and HAT has been targeted for elimination. At low disease prevalence, integration of case finding into routine activities of peripheral health centres becomes crucial... |
MS Word - 16.0 KB -
MD5: 9fa7421eb9c0fc53ff7ab8e054087e19
Metadata of data file DiTECT-HAT-WP2-GN-deidentified-2022-10-12 (data dictionary, in French and in English) |
Tabular Data - 458.0 KB - 62 Variables, 2402 Observations - UNF:6:5xfmuyoW9wsYi66d23V96w==
DiTECT-HAT-WP2 de-identified data (data dictionary: refer to DiTECT-HAT-WP2-GN-deidentified-2022-10-12 Metadata.docx) |
Adobe PDF - 617.4 KB -
MD5: e7aeb2275fff6c1e7f0db04403889be7
Informed consent form and assent form, in French |
Adobe PDF - 1.9 MB -
MD5: ff5e9506b784d9bdb8b63ca3809d5238
Study protocol in English |
Adobe PDF - 2.2 MB -
MD5: b26bfac54b600072c0a232905b78aaac
Study protocol in French |
Sep 6, 2022 - DiTECT-HAT
Lejon, Veerle; Ngay Lukusa, Ipos; Mumba Ngoyi, Dieudonné; Van Reet, Nick; Buscher, Philippe, 2022, "Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP4 Early test-of-cure", https://doi.org/10.23708/MBMROD, DataSuds, V2
In the last decade, the prevalence of Trypanosoma brucei gambiense human African trypanosomiasis (HAT) has fallen and HAT has been targeted for elimination. Clinical trials on safe and efficacious drugs for HAT, applicable in an elimination context, would be accelerated by availa... |
Sep 6, 2022 -
Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP4 Early test-of-cure
MS Word - 25.1 KB -
MD5: ebb2dc6dc63e3b4c9d6ed4f9cb660bc0
Addendum to DiTECT-HAT-WP4 protocol (august 2020) |
